Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Circulating KIM-1 and ctDNA as prognostic markers in oligometastatic clear cell renal cell carcinoma (ccRCC): The K-COMPASS model.

ASCO GU 2026 abstract 537: among 112 patients, baseline and 3-month KIM-1 and ctDNA MRD were each associated with STFS in univariable and multivariable analyses; K-COMPASS (baseline KIM-1, baseline ctDNA MRD, and four clinical variables) had C-index 0.76 and calibration slope 1.

ASCO Genitourinary Cancers Symposium 2026, Abstract 537 2026